Annual Retained Earnings
-$88.68 M
-$24.86 M-38.95%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual retained earnings is -$88.68 million, with the most recent change of -$24.86 million (-38.95%) on December 31, 2023.
- During the last 3 years, CMMB annual retained earnings has fallen by -$64.98 million (-274.25%).
- CMMB annual retained earnings is now -274.25% below its all-time high of -$23.70 million, reached on December 31, 2020.
Performance
CMMB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$99.66 M
-$3.48 M-3.62%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly retained earnings is -$99.66 million, with the most recent change of -$3.48 million (-3.62%) on September 1, 2024.
- Over the past year, CMMB quarterly retained earnings has dropped by -$3.48 million (-3.62%).
- CMMB quarterly retained earnings is now -320.60% below its all-time high of -$23.70 million, reached on December 31, 2020.
Performance
CMMB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CMMB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.0% | -3.6% |
| 3 y3 years | -274.3% | -3.6% |
| 5 y5 years | -274.3% | -3.6% |
CMMB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -145.2% | at low | -175.5% | at low |
| 5 y | 5-year | -274.3% | at low | -320.6% | at low |
| alltime | all time | -274.3% | at low | -320.6% | at low |
Chemomab Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$99.66 M(+3.6%) |
| Jun 2024 | - | -$96.18 M(+3.9%) |
| Mar 2024 | - | -$92.55 M(+4.4%) |
| Dec 2023 | -$88.68 M(+39.0%) | -$88.68 M(+10.1%) |
| Jun 2023 | - | -$80.54 M(+11.0%) |
| Mar 2023 | - | -$72.57 M(+13.7%) |
| Dec 2022 | -$63.82 M | -$63.82 M(+14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$55.55 M(+17.0%) |
| Jun 2022 | - | -$47.47 M(+15.0%) |
| Mar 2022 | - | -$41.28 M(+14.1%) |
| Dec 2021 | -$36.17 M(+52.7%) | -$36.17 M(+16.2%) |
| Sep 2021 | - | -$31.14 M(+10.5%) |
| Jun 2021 | - | -$28.17 M(+10.9%) |
| Mar 2021 | - | -$25.40 M(+7.2%) |
| Dec 2020 | -$23.70 M | -$23.70 M |
FAQ
- What is Chemomab Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual retained earnings year-on-year change?
- What is Chemomab Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly retained earnings year-on-year change?
What is Chemomab Therapeutics annual retained earnings?
The current annual retained earnings of CMMB is -$88.68 M
What is the all time high annual retained earnings for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual retained earnings is -$23.70 M
What is Chemomab Therapeutics annual retained earnings year-on-year change?
Over the past year, CMMB annual retained earnings has changed by -$24.86 M (-38.95%)
What is Chemomab Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CMMB is -$99.66 M
What is the all time high quarterly retained earnings for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly retained earnings is -$23.70 M
What is Chemomab Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CMMB quarterly retained earnings has changed by -$3.48 M (-3.62%)